Here, BPC 157 was suggested to be a link between IBD and multiple sclerosis, that could be also used in practice per-orally (as an anti-ulcer peptide, stable in human gastric juice) (5-7, 9), and thereby, being equally effective against the models of both of those diseases
See more During the extensive two-year review process for the 2021 version of the Code, WADA received considerable stakeholder feedback related to drugs of abuse where it was felt that the use of some substances included in the Prohibited List was often unrelated to sport practice
A 2009 study looking at dosing rats with oral BPC-157 found that the effectiveness of the peptide therapy was certainly present and that positive effectiveness was present
Preservative: 0.9% benzyl alcohol
The absence of documented adverse events reflects the absence of studies, not proven safety
With proper preparation and storage, bacteriostatic water can help keep your peptide solutions stable for safe administration into your body
